The value of ultrasound (US) in the diagnosis of prostate cancer;Sonographie des prostatakarzinoms: Derzeitiger stand und zukunftsperspektiven

Radiologe

Volumn 43, Issue 6, 2003, Pages 455-463

  Frauscher, F ^a   Klauser, A ^a   Berger, A P ^b   Halpern, E J ^b   Feuchtner, G ^a   Koppelstaetter, F ^a   Pallwein, L ^a   Pinggera, G M ^b   Weirich, H ^a   Horninger, W ^b   Bartsch, G ^b   Zur Nedden, D ^a  

^a Univ Klinik für Allgemeine Psychiatrie und Sozialpsychiatrie   (Austria)

^b NONE

Author keywords

Contrast agents; Diseases; Doppler studies; Prostate; Ultrasound

Indexed keywords

CONTRAST MEDIUM;

BLOOD FLOW; CANCER STAGING; ECHOGRAPHY; GRAY SCALE ECHOGRAPHY; HUMAN; PROSTATE; PROSTATE CANCER; REVIEW; TECHNIQUE;

BIOPSY; CLINICAL TRIALS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; POLYSACCHARIDES; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0038266678     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-003-0914-7     Document Type: Review

References (54)

1. De la Rosette JJ, Aarnink RG (1995) New developments in ultrasonography for the detection of prostate cancer. J Endourol 1S:93-105
2. Frentzel-Beyne B (1994) Sonography of the prostate. Radiologe 34:109-115
3. Hammerer PG (1994) Sonographic diagnosis of prostatic cancer. Radiologe 34:116-121
4. Watanabe H (1989) History and application of transrectal ultrasonography of the prostate. Urol Clin North Am 16:617-622
5. Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics 2001.CA Cancer J Clin 51:1S-36
6. Carter HB, Coffey DS (1990) The prostate: an increasing medical problem. Prostate 16:39-48
7. Scardino PT, Weaver R, Hudson MA (1992) Early detection of prostate cancer. Human Pathol 23:211-212
8. Rifkin MD (1997) Ultrasound of the prostate. Lippincott-Raven, New York
9. Rifkin MD (1998) Prostate cancer: the diagnostic dilemma and the place of imaging in detection and staging. World J Urol 16:76-80
10. Bartsch G, Egender G, Hubscher H, Rohr H (1982) Sonometrics of the prostate. J Urol 127:1119-1121
11. Rifkin MD, Alexander AA, Pisarchick J, Matteucci T (1991) Palpable masses in the prostate: superior accuracy of US-guided biopsy compared with accuracy of digitally guided biopsy. Radiology 179:41-47
12. Spencer JA, Alexander AA, Gomella L, Matteucci T, Goldberg BB (1994) Ultrasound-guided four quadrant biopsy of the prostate: efficacy in the diagnosis of isoechoic cancer. Clin Radiol 49:711-714
13. Weaver RP, Noble MJ, Weigel JW (1991) Correlation of ultrasound guided and digitally guided directed transrectal biopsies of palpable prostatic abnormalities. J Urol 145:516-518
14. Rifkin MD, Sudakoff GS, Alexander AA (1993) Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 186:509-513
15. Kelly IM, Lees WR, Rickards D (1993) Prostate cancer and the role of color Doppler US. Radiology 189:153-156
16. Newman JS, Bree RL, Rubin JM (1995) Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 195:86-90
17. Littrup PJ, Klein RM, Gross ML, Sparschu RA, Segel MC, Zingas AP (1995) Color Doppler of the prostate: histologic and racial correlations (abstr). Radiology 197:365
18. Ismail M, Petersen RO, Alexander AA, Newschaffer C, Gomella LG (1997) Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology 50:906-912
19. Ismail M, Gomella LG, Alexander AA (1997) Color Doppler sonography of the prostate. Tech Urol 3:140-146
20. Alexander AA (1995) To color Doppler image the prostate or not: that is the question. Radiology 195:11-13
21. Rifkin MD, Alexander AA, Helinek TG, Merton DA (1991) Color Doppler as an adjunct to prostate ultrasound. Scand J Urol Nephrol 137 [suppl]:85-89
22. Sillman F, Boyce J, Fruchter R (1981) The significance of atypical vessels and neovascularization in cervical neoplasia. Am J Obstet Gynecol 139:154-159
23. Srivastava A, Laidler P, Davies RP et al. (1988) The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 133:419-423
24. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324:1-8
25. Brawer MK, Deering RE, Brown M et al. (1994) Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 73:678-687
26. Fleischer AC, Rodgers WH, Rao BK et al. (1991) Assessment of ovarian tumor vascularity with transvaginal color Doppler sonography. J Ultrasound Med 10:563-568
27. Neumaier CE, Martinoli C, Derchi LE, Silvestri E, Rosenberg I (1995) Normal prostate gland: examination with color Doppler US. Radiology 196:453-457
28. Leventis AK, Shariat SF, Utsunomiya T, Slawin KM (2001) Characteristics of normal prostate vascular anatomy as displayed by power Doppler. Prostate 46:281-288
29. Halpern EJ, Frauscher F, Forsberg F et al. (2002) High frequency Doppler imaging of the prostate: impact of patient position. Radiology 225:71-77
30. Cho JY, Kim SH, Lee SE (1998) Diffuse prostatic lesions: role of color and power Doppler ultrasonography. J Ultrasound Med 17:283-287
31. Halpern EJ, Strup SE (2000) Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR 174:623-627
32. Louvar E, Littrup PJ, Goldstein A et al. (1998) Correlation of color Doppler flow in the prostate with tissue microvascularity. Cancer 83:135-140
33. Kedar RP, Cosgrove D, McCready VR et al. (1996) Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology 198:679-686
34. Forsberg F, Merton DA, Liu JB et al. (1998) Clinical applications of ultrasound contrast agents. Ultrasonics 36:695-701
35. Forsberg F, Liu JB, Burns PN et al. (1994) Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 13:357-365
36. Goldberg BB, Liu JB, Forsberg F (1994) Ultrasound contrast agents: a review. Ultrasound Med Biol 20:319-333
37. Frauscher F, Helweg G, Gotwald TF et al. (1998) The value of contrast-enhanced color Doppler ultrasonography in the diagnosis of prostate cancer (abstr). Radiology 209:417
38. Bree RL, DeDreu SE (1998) Contrast enhanced color Doppler of the prostate as an adjunct to grayscale identification of cancer prior to biopsy (abstr). Radiology 209:418
39. Frauscher F, Klauser A, Halpern EJ, Horninger W, Bartsch G (2001) Detection of prostate cancer using a microbubble ultrasound contrast agent. Lancet 357:1849-1850
40. Frauscher F, Klauser A, Volgger H et al. (2002). Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection.J Urol 167:1648-1652
41. Bogers HA, Sedelaar JP, Beerlage HP et al. (1999) Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54:97-104
42. Unal D, Sedelaar JP, Aarnink RG et al. (2000) Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer. BJU Int 86:58-64
43. Eckersley RJ, Sedelaar JP, Blomley MJ et al. (2002) Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate 51:256-267
44. Strohmeyer D, Frauscher F, Klauser A et al. (2001) Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. Anticancer Res 21:2907-2913
45. Albrecht T, Hoffmann CW, Schettler S et al. (2000) B-mode enhancement at phase-inversion US with air-based microbubble contrast agent: initial experience in humans. Radiology 216:273-278
46. Halpern EJ, Verkh L, Forsberg F et al. (2000) Initial experience with contrast-enhanced sonography of the prostate. AJR 174:1575-1580
47. Halpern EJ, Rosenberg M, Gomella LG (2001) Contrast enhanced sonography of the prostate: Radiology 219:219-225
48. Halpern EJ, McCue PA, Aksnes AK, Hagen EK, Frauscher F, Gomella, LG (2002) Contrast enhanced sonography of the prostate: correlation with whole mount prostatectomy specimens. Radiology 222:361-366
49. Shi WT, Forsberg F, Hall AL et al. (1999) Subharmonic imaging with contrast agents: initial results. Ultrason Imaging 21:79-94
50. Forsberg F, Shi WT, Goldberg BB (2000) Subharmonic imaging of contrast agents. Ultrasonics 38:93-98
51. Huber S, Delorme S, Knopp MV et al. (1994) Breast tumors: computer-assisted quantitative assessment with color Doppler US. Radiology 192:797-801
52. Cosgrove DO, Bamber JC, Davey JB et al. (1990) Color Doppler signals from breast tumors. Work in progress. Radiology 176:175-180
53. Huber S, Helbich T, Kettenbach J et al. (1998) Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US - early experience. Radiology 208:485-489
54. Goossen TE, de la Rosette JJ, Hulsbergen-van de Kaa CA, van Leenders GJ, Wijkstra H (2003) The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol 43:124-131